Literature DB >> 21978978

Hepatic and renal manifestations in autosomal dominant polycystic kidney disease: a dichotomy of two ends of a spectrum.

J J M van Gulick1, T J G Gevers, L van Keimpema, J P H Drenth.   

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is a multisystem disorder. It is the most common genetic cause of end-stage renal disease. One frequent extra-renal manifestation is hepatic cyst formation. The majority of ADPKD patients develop complications as a result of renal cyst formation; however, a small proportion develop extensive hepatic disease with minor renal features. Both phenotypes seem to represent the spectrum of ADPKD. This review discusses the current understanding of the pathogenesis of the disease, its manifestations and the mechanisms of cyst formation. Furthermore, it focuses on monitoring the disease and the treatment options currently available.

Entities:  

Mesh:

Year:  2011        PMID: 21978978

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  5 in total

Review 1.  Diagnosis and management of polycystic liver disease.

Authors:  Tom J G Gevers; Joost P H Drenth
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-01-08       Impact factor: 46.802

2.  Conditional mesenchymal disruption of pkd1 results in osteopenia and polycystic kidney disease.

Authors:  Ni Qiu; Zhousheng Xiao; Li Cao; Valentin David; Leigh Darryl Quarles
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

3.  Biogenesis of mammalian microRNAs by a non-canonical processing pathway.

Authors:  Mallory A Havens; Ashley A Reich; Dominik M Duelli; Michelle L Hastings
Journal:  Nucleic Acids Res       Date:  2012-01-23       Impact factor: 16.971

4.  Rationale and design of the RESOLVE trial: lanreotide as a volume reducing treatment for polycystic livers in patients with autosomal dominant polycystic kidney disease.

Authors:  Tom J G Gevers; Melissa Chrispijn; Jack F M Wetzels; Joost P H Drenth
Journal:  BMC Nephrol       Date:  2012-04-04       Impact factor: 2.388

5.  Infectious Hepatic Cyst: An Underestimated Complication.

Authors:  Kazuhiko Morii; Takeharu Yamamoto; Shinichiro Nakamura; Hiroaki Okushin
Journal:  Intern Med       Date:  2018-03-09       Impact factor: 1.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.